J Clin Immunol. 2026 Mar 6. doi: 10.1007/s10875-026-01989-0. Online ahead of print. NO ABSTRACT PMID:41790376 | DOI:10.1007/s10875-026-01989-0
J Clin Immunol. 2026 Mar 4;46(1):23. doi: 10.1007/s10875-026-01988-1. NO ABSTRACT PMID:41781714 | DOI:10.1007/s10875-026-01988-1
J Clin Immunol. 2026 Mar 2. doi: 10.1007/s10875-026-01994-3. Online ahead of print. ABSTRACT AIM: Idiopathic nephrotic syndrome (INS) is the most common glomerular disease in children, but its underlying mechanisms remain unclear. Although glucocorticoids (GC) are the first-line treatment, approximately 10% of INS cases are steroid-resistant (SRNS), and 50% may progress to refractory nephrotic syndrome … Read more
J Clin Immunol. 2026 Feb 28. doi: 10.1007/s10875-026-01985-4. Online ahead of print. NO ABSTRACT PMID:41762359 | DOI:10.1007/s10875-026-01985-4
J Clin Immunol. 2026 Feb 26. doi: 10.1007/s10875-026-01990-7. Online ahead of print. NO ABSTRACT PMID:41746515 | DOI:10.1007/s10875-026-01990-7
J Clin Immunol. 2026 Feb 26. doi: 10.1007/s10875-026-01996-1. Online ahead of print. NO ABSTRACT PMID:41748971 | DOI:10.1007/s10875-026-01996-1
J Clin Immunol. 2026 Feb 20. doi: 10.1007/s10875-026-01986-3. Online ahead of print. NO ABSTRACT PMID:41718912 | DOI:10.1007/s10875-026-01986-3
J Clin Immunol. 2026 Feb 20. doi: 10.1007/s10875-026-01999-y. Online ahead of print. NO ABSTRACT PMID:41714512 | DOI:10.1007/s10875-026-01999-y
J Clin Immunol. 2026 Feb 17. doi: 10.1007/s10875-026-01992-5. Online ahead of print. NO ABSTRACT PMID:41701387 | DOI:10.1007/s10875-026-01992-5
J Clin Immunol. 2026 Feb 14. doi: 10.1007/s10875-026-01993-4. Online ahead of print. NO ABSTRACT PMID:41688586 | DOI:10.1007/s10875-026-01993-4
